Taken together, reasons underlying the apparently conflicting findings on the role of PD-L1 expression in prognosis of stage III unresectable NSCLC may include differences in the antibodies used, variable threshold levels for PD-L1, and interstudy variation in terms of the histological subtypes. Here, CD274 is linked to non-small cell lung carcinoma.